ORTHENE 90S

SECTION 2: Hazards identification

EMERGENCY OVERVIEW CAUTION: - HARMFUL IF SWALLOWED - CAUSES EYE IRRITATION - AVOID BREATHING DUST OR SPRAY MIST - AVOID CONTACT WITH EYES, SKIN OR CLOTHING - KEEP OUT OF REACH OF CHILDREN

Potential health effects

Acute Toxicity (Primary Routes of Exposure) Signs and Symptoms of Systemic Effects: This product contains a cholinesterase inhibitor. Signs and symptoms that may be seen, usually within several hours of exposure, include but are not limited to, headaches, dizziness, weakness, constriction of the pupil, blurred or dark vision, excessive salivation or nasal discharge, profuse sweating, abdominal cramps, nausea, diarrhea and vomiting. Severe poisonings may result in incontinence, unconsciousness, convulsions and death. Eye: This product is expected to cause minimal or no eye irritation. The degree of injury will depend on the amount and duration of contact and the speed and thoroughness of the first aid treatment. The expected adverse health effects resulting from an exposure may include redness and possibly some minor swelling. Skin: This product is expected to cause brief and/or minor irritation. The degree of injury will depend on the amount and duration of contact and the speed and thoroughness of the first aid treatment. The expected adverse health effects resulting from an exposure may include redness and possibly some minor swelling. This product is not expected to cause allergic skin reactions. This product has been shown to be slightly toxic when absorbed through the skin. The degree of injury will depend on the amount of material inhaled and the speed and thoroughness of the first aid treatment. The expected adverse systemic health effects are described above. Ingestion: This product has been shown to be slightly toxic when ingested. The degree of injury will depend on the amount of material ingested and the speed and thoroughness of the first aid treatment. The expected adverse systemic health effects are described above. Inhalation: Based on an evaluation of the ingredients and/or similar products, this product is expected to be minimally toxic when inhaled. The degree of injury will depend on the amount of material inhaled and the speed and thoroughness of the first aid treatment. The expected adverse systemic health effects are described above. Exposure to high concentrations of dust may result in respiratory irritation. Signs and symptoms may include, but not be limited to, nasal discharge, sore throat, coughing and difficulty in breathing. EMERGENCY TELEPHONE #: (800) 892-0099 NDA – No Data Available NA – Not Applicable MSDS Number: 0014 Revision Number: 6 Revision Date: 05/30/2000 Chronic Toxicity (Including Cancer): High doses of Acephate Technical have produced cancer in mice but there is no evidence that Acephate Technical causes cancer in humans. EPA has classified acephate as a Group C (possible) human carcinogen based on the cancer produced in female mice. This product is not listed as a carcinogen by the National Toxicology Program (NTP), the International Agency for Research on Cancer (IARC), or the Occupational Safety and Health Administration (OSHA). Teratology (Birth Defects) Information: There is no evidence that Acephate Technical causes birth defects. Reproduction Information: There is no evidence that Acephate Technical causes reproductive effects in humans. Potentially Aggravated Condition: Individuals with preexisting medical conditions which lower cholinesterase levels may have increased susceptibility to cholinesterase depression. For complete discussion of the toxicology data from which this evaluation was made, refer to Section 11. For Regulatory Information, refer to Section 15.